MRK003, a Gamma Secretase Inhibitor exhibits promising in vitro pre-clinical activity in Multiple Myeloma and Non Hodgkin's Lymphoma

類似資料

• TG101209, a novel JAK2 inhibitor, has significant in-vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
  著者:: Ramakrishnan, Vijay, 等
  出版事項: (2010)
• Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway
  著者:: Ramakrishnan, Vijay, 等
  出版事項: (2012)
• Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001
  著者:: Ramakrishnan, Vijay, 等
  出版事項: (2014)
• Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
  著者:: Ramakrishnan, Vijay, 等
  出版事項: (2011)
• Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
  著者:: Ramakrishnan, V, 等
  出版事項: (2009)